Journey Medical Corporation will announce its third quarter 2026 financial results on November 12, 2026, after U.S. markets close. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a corporate update. Journey Medical focuses on FDA-approved prescription drugs for dermatological conditions and currently markets nine branded products. Investors can register to join the call or listen via webcast on the company's website.
Journey Medical Corporation's upcoming Q3 2026 results provide context for health sector activity on Pluang. As of Nov 05, 2026 19:42 WIB, 87 of 150 priced health-sector US stocks rose while 56 fell. Notable movers include Acadia Healthcare Company Inc at USD 34.25 with a 6.20% gain and Becton Dickinson and Co at USD 197.10 with a 5.78% loss.
Scout Clean Energy has announced that its 183 MW Nimbus Wind Farm in Carroll County, Arkansas, is now commercially operational after two years of construction. The wind farm, the largest in Arkansas, generates enough electricity to power over 40,000 ...
CRCAM Toulouse 31 announced the publication and filing of its financial information report for the quarter ending September 30, 2026. The report is accessible to the public on the company's website under the regulatory information section for 2026. T...
Global tech giants like Amazon, Google, and Microsoft are committing hundreds of billions of dollars to expand AI-focused data center accelerators, driven by surging demand from generative AI workloads that exceed traditional CPU capabilities. These ...
Berkshire Hathaway's stock portfolio is now worth about three times what the company originally paid for it. These gains alone represent roughly 19% of Berkshire Hathaway's total company value, highlighting the significant growth and value generated ...
C3is Inc. will implement a one-for-five reverse stock split effective November 9, 2026, reducing its outstanding shares from about 4.2 million to 0.84 million. This move aims to increase the stock price to meet Nasdaq's minimum bid price requirement ...
